PIMA530012
Influenza A H9N2 HA (A/Hong Kong/1073/99) Monoclonal Antibody (13), Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIMA530012-Each-of-1 | In Stock | ₹ 47,481.50 |
PIMA530012 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 47,481.50
GST (18%): ₹ 8,546.67
Total Price: ₹ 56,028.17
Antigen
Influenza A H9N2 HA (A/Hong Kong/1073/99)
Classification
Monoclonal
Concentration
1 mg/mL
Formulation
PBS with no preservative
Host Species
Mouse
Purification Method
Protein A
Regulatory Status
RUO
Target Species
Virus
Product Type
Antibody
Applications
ELISA
Clone
13
Conjugate
Unconjugated
Gene Alias
flu hemagglutinin; H9N2 HA; H9N2 hemagglutinin; Influenza H9N2; influenza hemagglutinin
Immunogen
Recombinant Influenza A H9N2 (A/Hong Kong/1073/99) Hemagglutinin/HA Protein
Quantity
100μL
Primary or Secondary
Primary
Content And Storage
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Form
Liquid
Related Products
Description
- This product is preservative free
- It is recommended to add sodium azide to avoid contamination (final concentration 0.05%-0.1%)
- This antibody has specificity for Influenza A H9N2 (A/Hong Kong/1073/99) Hemagglutinin/HA
- Influenza viruses consists of three types (Influenza A, B, and C), which make up three of the five genera in the Orthomyxoviridae family
- Commonly know as the flu, influenza strains can affect both birds and mammals
- Influenza strains form roughly spherical particles and are similar in composition with viral envelope containing two main types of glycoproteins (hemagglutinin and neuraminidase), wrapped around the central core of the viral RNA genome and other viral proteins that package and protect the RNA
- Unusually for a virus, the influenzavirus genome is not a single piece of nucleic acid; rather a seven to eight segmented fragments of negative-sense RNA with each fragment expressing different viral proteins
- Influenza spreads seasonally, resulting in about three to five million yearly cases of severe illness and about 250,000 to 500,000 deaths annually or into the millions in pandemic years.